The global Glucokinase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Glucokinase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucokinase market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glucokinase in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glucokinase manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others

Segment by Application
Metabolic Disorder
Obesity
Diabetes
Others